Conditional Molecule Generator

Conditional Molecule Generator generates molecular graphs for de novo drug design using conditional deep generative models.


Key Features:

  • Graph-Based Generation: Employs sequential graph generators to create molecular graphs instead of SMILES strings and is optimized for molecule generation.
  • Atom-Level Recurrent Units Avoidance: Operates without atom-level recurrent units, reducing the computational expense associated with those units.
  • Deep Generative Models: Leverages advanced deep generative models for de novo molecule generation.
  • Scalability: Scaled to accommodate significantly larger and more complex molecules from the ChEMBL database, expanding covered chemical space.
  • Performance Superiority: Outperforms SMILES-based models by producing valid molecular outputs at a higher rate.
  • Conditional Generation: Uses a conditional graph generative model to generate molecules according to multiple objectives and design criteria.

Scientific Applications:

  • Scaffold-Based Generation: Generates compounds containing predefined molecular scaffolds to facilitate exploration of novel chemical entities.
  • Drug-Likeness and Synthetic Accessibility: Produces molecules that meet specified drug-likeness criteria and synthetic accessibility considerations.
  • Dual Inhibitor Design: Has been applied to generate dual inhibitors targeting JNK3 and GSK-3β.

Methodology:

Implements a conditional graph generative model using sequential graph generation techniques that focus on molecular graphs rather than SMILES and avoids atom-level recurrent units.

Topics

Details

License:
Apache-2.0
Tool Type:
command-line tool
Operating Systems:
Linux, Mac
Programming Languages:
Python
Added:
8/24/2018
Last Updated:
11/25/2024

Operations

Publications

Li Y, Zhang L, Liu Z. Multi-objective de novo drug design with conditional graph generative model. Journal of Cheminformatics. 2018;10(1). doi:10.1186/s13321-018-0287-6. PMID:30043127. PMCID:PMC6057868.

PMID: 30043127
PMCID: PMC6057868
Funding: - National Natural Science Foundation of China: 21572010, 21772005, 81573273, 81673279 - National Major Scientific and Technological Special Project for “Significant New Drugs Development”: 2018ZX09735001-003

Documentation